Docetaxel and oxaliplatin combination as second-line treatment in patients with advanced gastric cancer

Docetaxel and oxaliplatin combination as second-line treatment in patients with advanced gastric cancer
复制标题

多西他赛联合奥沙利铂二线治疗晚期胃癌

DOI:
10.1200/jco.2005.23.16_suppl.4188
复制
发表时间:
2005
影响因子:
45.3
通讯作者:
C. Barone
C. Barone
中科院分区:
医学1区
文献类型:
--
作者:
G. Schinzari;E. D'Argento;M. Quirino;M. Basso;N. Trigila;G. Leonardo;A. Cassano;C. Pozzo;C. Barone

文献摘要

被引文献

相似文献

4188背景:化疗是进展期胃癌(PTS)患者的唯一治疗选择。一线方案能够轻微但显著地提高存活率。
4188 Background: Chemotherapy is the only treatment option for advanced gastric cancer (AGC) patients (pts). First line regimens are able to provide a slight but significant increase of survival ra...